ReviewInternational journal of environmental research and public health2011
Improving public health through access to and utilization of medication assisted treatment.
Review in International journal of environmental research and public health, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
23 citing papers in PubMed, 41 citations in OpenAlex.
- Retention and dropout from sublingual and extended-release buprenorphine treatment: A comparative analysis of data from a nationally representative sample of commercially-insured people with opioid use disorder in the United States.The International journal on drug policy · 2025Article
- Medication-Assisted Treatment in Problem-solving Courts: A National Survey of State and Local Court Coordinators.Journal of drug issues · 2023Article
- Awareness, perception and utilization of a mobile health clinic by people who use drugs.Annals of medicine · 2022Article
- Awareness and willingness to use HIV oral pre-exposure prophylaxis among people who inject drugs in Dar es Salaam, Tanzania: A cross-sectional survey.PLOS global public health · 2022Article
- Treatment trajectories and barriers in opioid agonist therapy for people who inject drugs in rural Puerto Rico.Journal of substance abuse treatment · 2021Article
- Prevalence and Geographic Distribution of Obstetrician-Gynecologists Who Treat Medicaid Enrollees and Are Trained to Prescribe Buprenorphine.JAMA network open · 2020Article
- Structural Determinants of Black MSM HIV Testing Coverage (2011-2016).AIDS and behavior · 2020Article
- Buprenorphine prescription dispensing rates and characteristics following federal changes in prescribing policy, 2017-2018: A cross-sectional study.Drug and alcohol dependence · 2020Article
- Predictors of historical change in drug treatment coverage among people who inject drugs in 90 large metropolitan areas in the USA, 1993-2007.Substance abuse treatment, prevention, and policy · 2020Article
- ACMT Position Statement: Remove the Waiver Requirement for Prescribing Buprenorphine for Opioid Use Disorder.Journal of medical toxicology : official journal of the American College of Medical Toxicology · 2019Article
- ACMT Position Statement: Buprenorphine Administration in the Emergency Department.Journal of medical toxicology : official journal of the American College of Medical Toxicology · 2019Article
- Sociodemographic factors, prescription history and opioid overdose deaths: a statewide analysis using linked PDMP and mortality data.Drug and alcohol dependence · 2018Observational
- Integrated Models of Care for Individuals with Opioid Use Disorder: How Do We Prevent HIV and HCV?Current HIV/AIDS reports · 2018Review
- Convenience without disclosure: a formative research study of a proposed integrated methadone and antiretroviral therapy service delivery model in Dar es Salaam, Tanzania.Addiction science & clinical practice · 2017Article
- Evaluation of a community-based integrated heroin addiction treatment model in Chinese patients.Oncotarget · 2017Article
- Prevalence and predictors of HCV among a cohort of opioid treatment patients in Dar es Salaam, Tanzania.The International journal on drug policy · 2017Article
- Intranasal naloxone and related strategies for opioid overdose intervention by nonmedical personnel: a review.Substance abuse and rehabilitation · 2017Review
- National and State Treatment Need and Capacity for Opioid Agonist Medication-Assisted Treatment.American journal of public health · 2015Article
- Use of pharmacotherapies in the treatment of alcohol use disorders and opioid dependence in primary care.BioMed research international · 2015Review
- Impact of research network participation on the adoption of buprenorphine for substance abuse treatment.Addictive behaviors · 2014Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Providing access to and utilization of medication assisted treatment (MAT) for the treatment of opioid abuse and dependence provides an important opportunity to improve public health. Access to health services comprising MAT in the community is fundamental to achieve broad service coverage. The type and placement of the health services comprising MAT and integration with primary medical care including human immunodeficiency virus (HIV) prevention, care and treatment services are optimal for addressing both substance abuse and co-occurring infectious diseases. As an HIV prevention intervention, integrated (same medical record for HIV services and MAT services) MAT with HIV prevention, care and treatment programs provides the best "one stop shopping" approach for health service utilization. Alternatively, MAT, medical and HIV services can be separately managed but co-located to allow convenient utilization of primary care, MAT and HIV services. A third approach is coordinated care and treatment, where primary care, MAT and HIV services are provided at distinct locations and case managers, peer facilitators, or others promote direct service utilization at the various locations. Developing a continuum of care for patients with opioid dependence throughout the stages MAT enhances the public health and Recovery from opioid dependence. As a stigmatized and medical disenfranchised population with multiple medical, psychological and social needs, people who inject drugs and are opioid dependent have difficulty accessing services and navigating medical systems of coordinated care. MAT programs that offer comprehensive services and medical care options can best contribute to improving the health of these individuals thereby enhancing the health of the community.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.